Changes in expression of discrete VGF fragments have been detected in different neurological and psychiatric conditions. In schizophrenia, one study has shown an increase in the VGF23-62 peptide and a subsequent small study demonstrated that drugs further increase the expression, pointing at a possible ameliorating action of the fragment. A decreased expression of VGF26-62 peptide was found in frontotemporal dementia and the expression of a fragment containing aminoacids 378-398 was found to be changing in amyotrophic lateral sclerosis and Alzheimer's disease. VGF expression has also been shown in damaged peripheral nerves, and it is thought to have a role in neuropathic pain. In Glioblastoma, VGF has been shown to play autocrine and paracrine roles in feedback loops between differentiated glioblastoma cells and glioblastoma-specific cancer stem cells, promoting growth, survival and self-renewal.
^Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest CA, Kozak CA, Boozer CN, Peng B, McEvoy RC, Good P, Kelley KA, Takahashi JS, Pintar JE, Roberts JL, Mobbs CV, Salton SR (July 1999). "Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance". Neuron. 23 (3): 537–48. doi:10.1016/S0896-6273(00)80806-5. PMID10433265.
^Rizzi R, Bartolomucci A, Moles A, D'Amato F, Sacerdote P, Levi A, La Corte G, Ciotti MT, Possenti R, Pavone F (August 2008). "The VGF-derived peptide TLQP-21: a new modulatory peptide for inflammatory pain". Neuroscience Letters. 441 (1): 129–33. doi:10.1016/j.neulet.2008.06.018. PMID18586396.
^Bartolomucci A, Moles A, Levi A, Possenti R (September 2008). "Pathophysiological role of TLQP-21: gastrointestinal and metabolic functions". Eating and Weight Disorders. 13 (3): e49–54. PMID19011364.
^D'Amato F, Noli B, Brancia C, Cocco C, Flore G, Collu M, Nicolussi P, Ferri GL (May 2008). "Differential distribution of VGF-derived peptides in the adrenal medulla and evidence for their selective modulation". The Journal of Endocrinology. 197 (2): 359–69. doi:10.1677/JOE-07-0346. PMID18434366.
^Jethwa PH, Ebling FJ (2008). "Role of VGF-derived peptides in the control of food intake, body weight and reproduction". Neuroendocrinology. 88 (2): 80–7. doi:10.1159/000127319. PMID18408361.
^Jiang, Cheng; Lin, Wei-Jye; Labonté, Benoit; Tamminga, Carol A.; Turecki, Gustavo; Nestler, Eric J.; Russo, Scott J.; Salton, Stephen R. (2018-11-20). "VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine". Neuropsychopharmacology. 44 (5): 971–981. doi:10.1038/s41386-018-0277-4. ISSN1740-634X. PMID30504797.
^Levi A, Ferri GL, Watson E, Possenti R, Salton SR (August 2004). "Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor". Cellular and Molecular Neurobiology. 24 (4): 517–33. doi:10.1023/B:CEMN.0000023627.79947.22. PMID15233376.
^Mandolesi G, Gargano S, Pennuto M, Illi B, Molfetta R, Soucek L, Mosca L, Levi A, Jucker R, Nasi S (January 2002). "NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interaction". FEBS Letters. 510 (1–2): 50–6. doi:10.1016/S0014-5793(01)03227-6. PMID11755530.
^Carrette O, Demalte I, Scherl A, Yalkinoglu O, Corthals G, Burkhard P, Hochstrasser DF, Sanchez JC (August 2003). "A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease". Proteomics. 3 (8): 1486–94. doi:10.1002/pmic.200300470. PMID12923774.